Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers
Clinical trial NCT02934464 · UNKNOWN
Trial details
- NCT number
- NCT02934464
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2021-12-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.